Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
Condition(s):X-linked Severe Combined Immunodeficiency (XSCID)Last Updated:March 27, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):X-linked Severe Combined Immunodeficiency (XSCID)Last Updated:March 27, 2024Recruiting
Condition(s):Severe Combined ImmunodeficiencyLast Updated:July 2, 2017Completed
Condition(s):Growth Failure; X-linked Severe Combined Immunodeficiency (XSCID); Growth Hormone ResistenceLast Updated:July 3, 2015Terminated
Condition(s):Severe Combined ImmunodeficiencyLast Updated:July 2, 2017Completed
Condition(s):X-Linked Combined Immunodeficiency DiseasesLast Updated:December 4, 2019Unknown status
Condition(s):Gene TherapyLast Updated:March 27, 2020Recruiting
Condition(s):X-linked Severe Combined ImmunodeficiencyLast Updated:September 28, 2021Completed
Condition(s):X-linked Severe Combined ImmunodeficiencyLast Updated:August 1, 2017Unknown status
Condition(s):Severe Combined Immunodeficiency, X-LinkedLast Updated:October 12, 2023Recruiting
Condition(s):SCID, X LinkedLast Updated:September 19, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.